133 related articles for article (PubMed ID: 30565685)
1. Lycorine inhibits melanoma cell migration and metastasis mainly through reducing intracellular levels of β-catenin and matrix metallopeptidase 9.
Zhang P; Zhang M; Yu D; Liu W; Hu L; Zhang B; Zhou Q; Cao Z
J Cell Physiol; 2019 Jul; 234(7):10566-10575. PubMed ID: 30565685
[TBL] [Abstract][Full Text] [Related]
2. Lycorine inhibits melanoma A375 cell growth and metastasis through the inactivation of the PI3K/AKT signaling pathway.
Jiang QQ; Liu WB
Med Sci (Paris); 2018 Oct; 34 Focus issue F1():33-38. PubMed ID: 30403172
[TBL] [Abstract][Full Text] [Related]
3. Lycorine inhibits the growth and metastasis of breast cancer through the blockage of STAT3 signaling pathway.
Wang J; Xu J; Xing G
Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):771-779. PubMed ID: 28910973
[TBL] [Abstract][Full Text] [Related]
4. Lycorine inhibits breast cancer growth and metastasis via inducing apoptosis and blocking Src/FAK-involved pathway.
Ying X; Huang A; Xing Y; Lan L; Yi Z; He P
Sci China Life Sci; 2017 Apr; 60(4):417-428. PubMed ID: 28251459
[TBL] [Abstract][Full Text] [Related]
5. Identification of molecular anti-metastasis mechanisms of lycorine in colorectal cancer by RNA-seq analysis.
Gao L; Feng Y; Ge C; Xu X; Wang S; Li X; Zhang K; Wang C; Dai F; Xie S
Phytomedicine; 2021 May; 85():153530. PubMed ID: 33761445
[TBL] [Abstract][Full Text] [Related]
6. Lycorine is a novel inhibitor of the growth and metastasis of hormone-refractory prostate cancer.
Hu M; Peng S; He Y; Qin M; Cong X; Xing Y; Liu M; Yi Z
Oncotarget; 2015 Jun; 6(17):15348-61. PubMed ID: 25915156
[TBL] [Abstract][Full Text] [Related]
7. Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight.
Lamoral-Theys D; Andolfi A; Van Goietsenoven G; Cimmino A; Le Calvé B; Wauthoz N; Mégalizzi V; Gras T; Bruyère C; Dubois J; Mathieu V; Kornienko A; Kiss R; Evidente A
J Med Chem; 2009 Oct; 52(20):6244-56. PubMed ID: 19788245
[TBL] [Abstract][Full Text] [Related]
8. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
[TBL] [Abstract][Full Text] [Related]
9. Lycorine inhibits cell proliferation and migration by inhibiting ROCK1/cofilin‑induced actin dynamics in HepG2 hepatoblastoma cells.
Liu W; Zhang Q; Tang Q; Hu C; Huang J; Liu Y; Lu Y; Wang Q; Li G; Zhang R
Oncol Rep; 2018 Oct; 40(4):2298-2306. PubMed ID: 30066939
[TBL] [Abstract][Full Text] [Related]
10. Lycorine hydrochloride inhibits metastatic melanoma cell-dominant vasculogenic mimicry.
Liu R; Cao Z; Tu J; Pan Y; Shang B; Zhang G; Bao M; Zhang S; Yang P; Zhou Q
Pigment Cell Melanoma Res; 2012 Sep; 25(5):630-8. PubMed ID: 22781316
[TBL] [Abstract][Full Text] [Related]
11. Silymarin targets β-catenin signaling in blocking migration/invasion of human melanoma cells.
Vaid M; Prasad R; Sun Q; Katiyar SK
PLoS One; 2011; 6(7):e23000. PubMed ID: 21829575
[TBL] [Abstract][Full Text] [Related]
12. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
13. Lycorine possesses notable anticancer potentials in on-small cell lung carcinoma cells via blocking Wnt/β-catenin signaling and epithelial-mesenchymal transition (EMT).
Sun Y; Wu P; Sun Y; Sharopov FS; Yang Q; Chen F; Wang P; Liang Z
Biochem Biophys Res Commun; 2018 Jan; 495(1):911-921. PubMed ID: 29127013
[TBL] [Abstract][Full Text] [Related]
14. Lycorine targets multiple myeloma stem cell-like cells by inhibition of Wnt/β-catenin pathway.
Wang H; Gong Y; Liang L; Xiao L; Yi H; Ye M; Roy M; Xia J; Zhou W; Yang C; Shen X; Zhang B; Li Z; Liu J; Zhou H; Xiao X
Br J Haematol; 2020 Jun; 189(6):1151-1164. PubMed ID: 32167591
[TBL] [Abstract][Full Text] [Related]
15. Lycorine inhibits cell proliferation and induced oxidative stress-mediated apoptosis via regulation of the JAK/STAT3 signaling pathway in HT-3 cells.
Shang H; Jang X; Shi L; Ma Y
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22882. PubMed ID: 34558146
[TBL] [Abstract][Full Text] [Related]
16. Lycorine improves peripheral nerve function by promoting Schwann cell autophagy via AMPK pathway activation and MMP9 downregulation in diabetic peripheral neuropathy.
Yuan Q; Zhang X; Wei W; Zhao J; Wu Y; Zhao S; Zhu L; Wang P; Hao J
Pharmacol Res; 2022 Jan; 175():105985. PubMed ID: 34863821
[TBL] [Abstract][Full Text] [Related]
17. Lycorine inhibited the cell growth of non-small cell lung cancer by modulating the miR-186/CDK1 axis.
Li L; Zhang Z; Yang Q; Ning M
Life Sci; 2019 Aug; 231():116528. PubMed ID: 31176784
[TBL] [Abstract][Full Text] [Related]
18. Lycorine induces apoptosis of bladder cancer T24 cells by inhibiting phospho-Akt and activating the intrinsic apoptotic cascade.
Wang C; Wang Q; Li X; Jin Z; Xu P; Xu N; Xu A; Xu Y; Zheng S; Zheng J; Liu C; Huang P
Biochem Biophys Res Commun; 2017 Jan; 483(1):197-202. PubMed ID: 28042037
[TBL] [Abstract][Full Text] [Related]
19. Celecoxib potentially inhibits metastasis of lung cancer promoted by surgery in mice, via suppression of the PGE2-modulated β-catenin pathway.
Zhang S; Da L; Yang X; Feng D; Yin R; Li M; Zhang Z; Jiang F; Xu L
Toxicol Lett; 2014 Mar; 225(2):201-7. PubMed ID: 24374173
[TBL] [Abstract][Full Text] [Related]
20. [Overexpression of Axin inhibits lymphoma cell invasion and metastasis in vitro by down-regulating β-catenin and MMP7/MMP9].
Li ZJ; Ye JZ; Zhan LY; Zheng ML
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Mar; 36(3):423-8. PubMed ID: 27063176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
